Plicamycin (patient information)

Jump to navigation Jump to search

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch. Template:Drug header

WikiDoc Resources for Plicamycin (patient information)

Articles

Most recent articles on Plicamycin (patient information)

Most cited articles on Plicamycin (patient information)

Review articles on Plicamycin (patient information)

Articles on Plicamycin (patient information) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Plicamycin (patient information)

Images of Plicamycin (patient information)

Photos of Plicamycin (patient information)

Podcasts & MP3s on Plicamycin (patient information)

Videos on Plicamycin (patient information)

Evidence Based Medicine

Cochrane Collaboration on Plicamycin (patient information)

Bandolier on Plicamycin (patient information)

TRIP on Plicamycin (patient information)

Clinical Trials

Ongoing Trials on Plicamycin (patient information) at Clinical Trials.gov

Trial results on Plicamycin (patient information)

Clinical Trials on Plicamycin (patient information) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Plicamycin (patient information)

NICE Guidance on Plicamycin (patient information)

NHS PRODIGY Guidance

FDA on Plicamycin (patient information)

CDC on Plicamycin (patient information)

Books

Books on Plicamycin (patient information)

News

Plicamycin (patient information) in the news

Be alerted to news on Plicamycin (patient information)

News trends on Plicamycin (patient information)

Commentary

Blogs on Plicamycin (patient information)

Definitions

Definitions of Plicamycin (patient information)

Patient Resources / Community

Patient resources on Plicamycin (patient information)

Discussion groups on Plicamycin (patient information)

Patient Handouts on Plicamycin (patient information)

Directions to Hospitals Treating Plicamycin (patient information)

Risk calculators and risk factors for Plicamycin (patient information)

Healthcare Provider Resources

Symptoms of Plicamycin (patient information)

Causes & Risk Factors for Plicamycin (patient information)

Diagnostic studies for Plicamycin (patient information)

Treatment of Plicamycin (patient information)

Continuing Medical Education (CME)

CME Programs on Plicamycin (patient information)

International

Plicamycin (patient information) en Espanol

Plicamycin (patient information) en Francais

Business

Plicamycin (patient information) in the Marketplace

Patents on Plicamycin (patient information)

Experimental / Informatics

List of terms related to Plicamycin (patient information)

IMPORTANT WARNING:

Plicamycin is no longer available in the U.S. If you are currently taking plicamycin, you should call your doctor to discuss switching to another treatment.

Plicamycin can cause a decrease in the number of blood cells in your bone marrow. Your doctor will order tests before, during, and after your treatment to see if your blood cells are affected by this drug.

About your treatment

Your doctor has ordered the drug plicamycin to help treat your illness. The drug is given by injection into a vein.

This medication is used to treat:

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Plicamycin is a type of antibiotic that is only used in cancer chemotherapy. It slows or stops the growth of cancer cells in your body. In addition, plicamycin may lower the amount of calcium in the blood. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer you have.

Other uses for this medicine

Plicamycin is also used to treat glioblastomas and Paget's disease of bone. Talk to your doctor about the possible risks of using this drug for your condition.

Precautions

Before taking plicamycin:

  • tell your doctor and pharmacist if you are allergic to plicamycin or any other drugs.
  • tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially aspirin and vitamins.
  • tell your doctor if you have or have ever had a bleeding disorder or liver or kidney disease.
  • you should know that plicamycin may interfere with the normal menstrual cycle (period) in women and may stop sperm production in men. However, you should not assume that you cannot get pregnant or that you cannot get someone else pregnant. Women who are pregnant or breast-feeding should tell their doctors before they begin taking this drug. You should not plan to have children while receiving chemotherapy or for a while after treatments. (Talk to your doctor for further details.) Use a reliable method of birth control to prevent pregnancy. Plicamycin may harm the fetus.
  • do not have any vaccinations (e.g., measles or flu shots) without talking to your doctor.

Side effects

Mild side effects

Side effects from plicamycin are common and include:

Tell your doctor if any of these symptoms are severe or last for several hours:

Severe side effects

If you experience any of the following symptoms, call your doctor immediately:

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/report.htm] or by phone [1-800-332-1088].

In case of emergency/overdose

In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.

Brand names

  • Mithracin®

Other names

  • Mithramycin

Template:SIB

Template:WH Template:WS